期刊
ONKOLOGIE
卷 34, 期 8-9, 页码 469-470出版社
KARGER
DOI: 10.1159/000331065
关键词
Tyrosine kinase inhibitor; Cholangiocarcinoma; Biliary tract cancer; Imatinib mesylate